Chemours Historical Balance Sheet

CC Stock

USD 14.10 0.57 3.89%

Trend analysis of Chemours Co balance sheet accounts such as Total Assets of 7.5 B or Other Current Liabilities of 537.9 M provides information on Chemours' total assets, liabilities, and equity, which is the actual value of Chemours to its prevalent stockholders. By breaking down trends over time using Chemours balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Chemours latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Chemours is a good buy for the upcoming year.

Chemours Inventory

1.21 Billion

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

About Chemours Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Chemours at a specified time, usually calculated after every quarter, six months, or one year. Chemours Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Chemours and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Chemours currently owns. An asset can also be divided into two categories, current and non-current.

Chemours Balance Sheet Chart

At present, Chemours' Total Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 1.1 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 138.6 M.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity Non Currrent Assets Other

Add Fundamental

Total Assets

Total assets refers to the total amount of Chemours assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Chemours books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Chemours balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Chemours Co are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Most accounts from Chemours' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Chemours current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	475M	1.2B	563M	537.9M
Total Assets	7.6B	8.3B	7.5B	7.5B

Other Current Liab Total Assets

Chemours balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment
Common Stock Shares Outstanding		-0.69	-0.51	-0.64	0.41	-0.66	-0.71	-0.82	-0.49	-0.81	-0.39	-0.65	-0.45	0.76	0.87	-0.51	-0.75	-0.39	0.66	-0.55	-0.75	-0.53	0.23	0.66	0.49	-0.63
Total Assets	-0.69		0.78	0.83	-0.72	0.83	0.77	0.5	0.7	0.86	0.43	0.84	0.85	-0.48	-0.81	0.87	0.64	0.46	-0.84	0.9	0.73	0.95	-0.66	-0.67	-0.84	0.67
Other Current Liab	-0.51	0.78		0.9	-0.8	0.74	0.41	0.51	0.41	0.52	0.28	0.75	0.8	-0.34	-0.62	0.8	0.33	0.69	-0.69	0.85	0.55	0.84	-0.73	-0.57	-0.8	0.28
Total Current Liabilities	-0.64	0.83	0.9		-0.61	0.73	0.45	0.62	0.7	0.59	0.42	0.82	0.65	-0.38	-0.73	0.67	0.6	0.72	-0.73	0.75	0.76	0.87	-0.51	-0.69	-0.66	0.31
Total Stockholder Equity	0.41	-0.72	-0.8	-0.61		-0.83	-0.49	-0.3	-0.28	-0.57	-0.4	-0.69	-0.97	0.26	0.63	-0.96	-0.18	-0.22	0.77	-0.95	-0.38	-0.72	0.92	0.5	0.97	-0.46
Other Liab	-0.66	0.83	0.74	0.73	-0.83		0.59	0.56	0.59	0.75	0.68	0.91	0.85	-0.32	-0.82	0.88	0.66	0.32	-0.78	0.89	0.74	0.77	-0.71	-0.66	-0.85	0.58
Property Plant And Equipment Net	-0.71	0.77	0.41	0.45	-0.49	0.59		0.36	0.34	0.96	0.12	0.48	0.61	-0.68	-0.59	0.65	0.52	0.25	-0.66	0.65	0.49	0.55	-0.34	-0.54	-0.59	0.94
Current Deferred Revenue	-0.82	0.5	0.51	0.62	-0.3	0.56	0.36		0.46	0.51	0.45	0.59	0.3	-0.37	-0.79	0.33	0.66	0.4	-0.46	0.39	0.59	0.43	-0.23	-0.66	-0.32	0.36
Accounts Payable	-0.49	0.7	0.41	0.7	-0.28	0.59	0.34	0.46		0.52	0.68	0.72	0.41	-0.07	-0.69	0.43	0.78	0.23	-0.58	0.49	0.75	0.72	-0.28	-0.56	-0.42	0.32
Non Current Assets Total	-0.81	0.86	0.52	0.59	-0.57	0.75	0.96	0.51	0.52		0.37	0.69	0.69	-0.67	-0.75	0.73	0.69	0.31	-0.74	0.74	0.67	0.66	-0.43	-0.67	-0.67	0.89
Non Currrent Assets Other	-0.39	0.43	0.28	0.42	-0.4	0.68	0.12	0.45	0.68	0.37		0.74	0.41	0.02	-0.63	0.42	0.62	-0.06	-0.4	0.44	0.6	0.41	-0.41	-0.52	-0.42	0.14
Other Assets	-0.65	0.84	0.75	0.82	-0.69	0.91	0.48	0.59	0.72	0.69	0.74		0.75	-0.34	-0.83	0.77	0.73	0.42	-0.74	0.81	0.87	0.81	-0.62	-0.7	-0.74	0.43
Long Term Debt	-0.45	0.85	0.8	0.65	-0.97	0.85	0.61	0.3	0.41	0.69	0.41	0.75		-0.31	-0.68	1.0	0.3	0.26	-0.81	0.99	0.47	0.83	-0.92	-0.54	-0.99	0.57
Net Receivables	0.76	-0.48	-0.34	-0.38	0.26	-0.32	-0.68	-0.37	-0.07	-0.67	0.02	-0.34	-0.31		0.48	-0.35	-0.37	-0.39	0.47	-0.37	-0.48	-0.31	0.06	0.35	0.35	-0.46
Good Will	0.87	-0.81	-0.62	-0.73	0.63	-0.82	-0.59	-0.79	-0.69	-0.75	-0.63	-0.83	-0.68	0.48		-0.71	-0.7	-0.23	0.76	-0.74	-0.8	-0.73	0.56	0.75	0.71	-0.59
Non Current Liabilities Total	-0.51	0.87	0.8	0.67	-0.96	0.88	0.65	0.33	0.43	0.73	0.42	0.77	1.0	-0.35	-0.71		0.35	0.28	-0.83	0.99	0.51	0.84	-0.89	-0.56	-0.99	0.61
Inventory	-0.75	0.64	0.33	0.6	-0.18	0.66	0.52	0.66	0.78	0.69	0.62	0.73	0.3	-0.37	-0.7	0.35		0.34	-0.53	0.4	0.84	0.52	-0.07	-0.5	-0.29	0.49
Other Current Assets	-0.39	0.46	0.69	0.72	-0.22	0.32	0.25	0.4	0.23	0.31	-0.06	0.42	0.26	-0.39	-0.23	0.28	0.34		-0.32	0.36	0.47	0.49	-0.11	-0.39	-0.23	0.03
Other Stockholder Equity	0.66	-0.84	-0.69	-0.73	0.77	-0.78	-0.66	-0.46	-0.58	-0.74	-0.4	-0.74	-0.81	0.47	0.76	-0.83	-0.53	-0.32		-0.85	-0.62	-0.78	0.58	0.62	0.83	-0.59
Total Liab	-0.55	0.9	0.85	0.75	-0.95	0.89	0.65	0.39	0.49	0.74	0.44	0.81	0.99	-0.37	-0.74	0.99	0.4	0.36	-0.85		0.57	0.88	-0.87	-0.61	-0.98	0.59
Property Plant And Equipment Gross	-0.75	0.73	0.55	0.76	-0.38	0.74	0.49	0.59	0.75	0.67	0.6	0.87	0.47	-0.48	-0.8	0.51	0.84	0.47	-0.62	0.57		0.66	-0.26	-0.68	-0.47	0.42
Total Current Assets	-0.53	0.95	0.84	0.87	-0.72	0.77	0.55	0.43	0.72	0.66	0.41	0.81	0.83	-0.31	-0.73	0.84	0.52	0.49	-0.78	0.88	0.66		-0.72	-0.58	-0.83	0.45
Short Term Debt	0.23	-0.66	-0.73	-0.51	0.92	-0.71	-0.34	-0.23	-0.28	-0.43	-0.41	-0.62	-0.92	0.06	0.56	-0.89	-0.07	-0.11	0.58	-0.87	-0.26	-0.72		0.4	0.91	-0.35
Intangible Assets	0.66	-0.67	-0.57	-0.69	0.5	-0.66	-0.54	-0.66	-0.56	-0.67	-0.52	-0.7	-0.54	0.35	0.75	-0.56	-0.5	-0.39	0.62	-0.61	-0.68	-0.58	0.4		0.53	-0.51
Common Stock	0.49	-0.84	-0.8	-0.66	0.97	-0.85	-0.59	-0.32	-0.42	-0.67	-0.42	-0.74	-0.99	0.35	0.71	-0.99	-0.29	-0.23	0.83	-0.98	-0.47	-0.83	0.91	0.53		-0.54
Property Plant Equipment	-0.63	0.67	0.28	0.31	-0.46	0.58	0.94	0.36	0.32	0.89	0.14	0.43	0.57	-0.46	-0.59	0.61	0.49	0.03	-0.59	0.59	0.42	0.45	-0.35	-0.51	-0.54

Click cells to compare fundamentals

Chemours Account Relationship Matchups

Chemours balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	166.3M	168.7M	158.3M	148.9M	150.0M	138.6M
Total Assets	7.1B	7.6B	7.6B	8.3B	7.5B	7.5B
Other Current Liab	449M	545M	475M	1.2B	563M	537.9M
Total Current Liabilities	1.4B	1.9B	1.9B	2.5B	1.8B	1.8B
Total Stockholder Equity	813M	1.1B	1.1B	737M	604M	1.1B
Other Liab	751M	626M	707M	854M	982.1M	711.9M
Property Plant And Equipment Net	3.7B	3.4B	3.4B	3.5B	3.4B	3.6B
Accounts Payable	820M	1.2B	1.2B	1.1B	1.1B	1.1B
Non Current Assets Total	4.4B	4.2B	4.4B	4.4B	4.5B	4.5B
Other Assets	292M	405M	547M	725M	833.8M	424.1M
Long Term Debt	4.0B	3.7B	3.6B	4.0B	4.1B	3.3B
Net Receivables	511M	720M	626M	610M	770M	603.4M
Liabilities And Stockholders Equity	7.1B	7.6B	7.6B	8.3B	7.5B	7.5B
Non Current Liabilities Total	4.8B	4.6B	4.6B	5.0B	5.1B	4.2B
Inventory	939M	1.1B	1.4B	1.4B	1.5B	1.2B
Other Current Assets	156M	150M	82M	670M	71M	67.5M
Other Stockholder Equity	(182M)	(303M)	(722M)	(773M)	(749M)	(711.6M)
Total Liab	6.3B	6.5B	6.5B	7.5B	6.9B	6.1B
Property Plant And Equipment Gross	3.7B	9.2B	9.4B	9.6B	9.8B	5.7B
Total Current Assets	2.6B	3.3B	3.2B	3.8B	3.0B	3.1B
Accumulated Other Comprehensive Income	(310M)	(364M)	(343M)	(274M)	(367M)	(385.4M)
Short Term Debt	78M	84M	141M	106M	54M	93.6M
Intangible Assets	21M	14M	6M	3M	2.7M	2.6M
Property Plant Equipment	3.9B	3.5B	3.4B	3.2B	3.6B	3.5B
Net Tangible Assets	515M	646M	973M	992M	892.8M	710.5M
Retained Earnings	1.3B	1.7B	2.2B	1.8B	1.7B	1.2B
Cash	1.1B	1.5B	1.1B	1.2B	713M	1.1B
Deferred Long Term Liab	148M	36M	49M	61M	54.9M	96.1M
Long Term Investments	167M	169M	175M	158M	152M	171.2M
Short Long Term Debt	134M	21M	25M	51M	54M	43.1M
Short Long Term Debt Total	4.3B	3.9B	3.8B	4.3B	4.4B	4.5B
Net Debt	3.2B	2.5B	2.7B	3.1B	3.6B	3.3B
Cash And Short Term Investments	1.1B	1.5B	1.1B	1.2B	713M	1.2B
Retained Earnings Total Equity	1.2B	1.3B	1.7B	2.2B	2.5B	2.6B
Long Term Debt Total	4.0B	4.0B	3.7B	3.6B	3.2B	3.1B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

How To Invest In Chemours

Details

Is Chemours Stock a good investment?

Details

What is Chemours' Net Worth?

Details

Largest Diversified Chemicals Companies

View

Largest Specialty Chemicals Companies

View

You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Is Diversified Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.65)

Dividend Share

Earnings Share

0.57

Revenue Per Share

38.677

Quarterly Revenue Growth

(0.01)

The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Chemours Historical Balance Sheet

Chemours Inventory

1.21 Billion

About Chemours Balance Sheet Analysis

Chemours Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Non Currrent Assets Other

Chemours balance sheet Correlations

Chemours Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Chemours balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 1.0	Long Term Debt
Total Liab	+ 0.99	Long Term Debt
Total Liab	+ 0.99	Non Current Liabilities Total
Common Stock	+ 0.97	Total Stockholder Equity
Non Current Assets Total	+ 0.96	Property Plant And Equipment Net
Total Current Assets	+ 0.95	Total Assets

Common Stock	- 0.99	Non Current Liabilities Total
Common Stock	- 0.99	Long Term Debt
Common Stock	- 0.98	Total Liab
Long Term Debt	- 0.97	Total Stockholder Equity
Non Current Liabilities Total	- 0.96	Total Stockholder Equity
Total Liab	- 0.95	Total Stockholder Equity